Hereditary Cancer Panel 57 ACMG 20 HBOC & 865 literature reviewed Genes

Description

Hereditary Cancer Panel 57 – Comprehensive Genetic Testing for Cancer Risk Assessment

Unlock the power of genetic insights with the Hereditary Cancer Panel 57 ACMG 20 HBOC & 865 Literature-Reviewed Genes, a cutting-edge genetic test designed to assess inherited cancer risks with unparalleled accuracy. This advanced panel analyzes 57 key genes, including the ACMG 20 and HBOC (Hereditary Breast and Ovarian Cancer) genes, alongside 865 literature-reviewed genes, providing a comprehensive evaluation of hereditary cancer predisposition.

### Key Features:
✅ Extensive Gene Coverage – Examines 57 clinically significant genes associated with hereditary cancers, including BRCA1, BRCA2, TP53, MLH1, MSH2, and more.
✅ ACMG 20 & HBOC Genes – Includes the 20 genes recommended by the American College of Medical Genetics (ACMG) for actionable findings, as well as genes linked to hereditary breast and ovarian cancer syndromes.
✅ 865 Literature-Reviewed Genes – Incorporates the latest scientific research to provide a broader understanding of potential genetic risks.
✅ Next-Generation Sequencing (NGS) Technology – Ensures high accuracy, sensitivity, and specificity in detecting pathogenic variants.
✅ Personalized Risk Assessment – Identifies inherited mutations that may increase susceptibility to various cancers, including breast, ovarian, colorectal, pancreatic, prostate, and more.
✅ Clinical Actionability – Provides valuable insights for early detection, prevention, and personalized treatment strategies.
✅ Genetic Counseling Support – Helps individuals and healthcare providers interpret results and make informed medical decisions.

### Benefits to the Customer:
🔹 Early Detection & Prevention – Identifying genetic predispositions allows for proactive health management, including increased surveillance, lifestyle modifications, and preventive measures.
🔹 Empowered Decision-Making – Enables individuals and families to make informed choices about their health, reproductive planning, and medical interventions.
🔹 Personalized Treatment Options – Supports precision medicine by guiding targeted therapies and tailored treatment plans based on genetic findings.
🔹 Family Health Insights – Helps relatives understand their potential genetic risks, promoting awareness and preventive care across generations.

### Who Should Consider This Test?
✔ Individuals with a family history of cancer (breast, ovarian, colorectal, pancreatic, prostate, etc.).
✔ Those with early-onset cancer diagnoses or multiple cancer occurrences in the family.
✔ Patients seeking personalized cancer risk assessment for proactive health management.
✔ Healthcare providers looking for comprehensive genetic insights to guide patient care.

Take control of your health with the Hereditary Cancer Panel 57—a powerful tool for understanding your genetic risks and making informed decisions for a healthier future.